Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Dietary omega-3 fats for treatment of inflammatory joint disease: Efficacy and utility
Rheumatic Disease Clinics of North America, 07/25/08
Print     Email This Article     Save in My Library   Free Abstract
Proudman SM et al. - There is high level evidence for symptomatic benefits from fish oil use in rheumatoid arthritis, and there is biologic plausibility for its clinical effects. Fish oil also has safety advantages in reducing cv risk.

  • Fish oil is not widely used in RA therapy, despite the following benefits:
  • There is high level evidence for symptomatic benefits
  • Biologic plausibility for its clinical effects (inhibition of inflammatory mediator production, production of anti-inflammatory mediators)
  • Reduction in use of NSAIDs, which confer cv risk and gastrointestinal adverse events
  • Cardioprotective effect in a patient population that has an inherent increased cv risk that is probably augmented by NSAID use

 

--- OSTEOARTHRITIS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

--- OTHER ARTHRITIS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

--- RHEUMATOID ARTHRITIS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.